Protein Sciences Corporation Release: Flublok® Influenza Vaccine Now Available for the 2014/2015 Influenza Season
MERIDEN, Conn., Sept. 29, 2014 /PRNewswire/ -- Protein Sciences Corporation, manufacturer of the revolutionary Flublok influenza vaccine, announced today that doses of the vaccine have been released and are now available for shipment.
Flublok is triple the strength of traditional flu vaccines and is the only flu vaccine made without eggs, antibiotics and influenza virus. Flublok is highly pure and does not contain thimerosal (mercury derivative), gelatin or latex.
Manon Cox, President and CEO of Protein Sciences said, "We are pleased to deliver Flublok on schedule and with ample time for people to get vaccinated this season." She continued, "Last year many consumers allergic to eggs or gelatin or those seeking a pure flu vaccine told us they were grateful to receive Flublok. By being earlier to market and having a wider distribution network this year we hope we can reach even more people who want or need Flublok."
Consumers looking for Flublok are encouraged to ask their healthcare professionals to order it for them. Flublok is also available at all Passport Health locations nationwide and select doctor's offices, clinics and pharmacies, a list of which is updated regularly and can be viewed at www.flublok.com/FlublokFinder.pdf.
Flublok has a unique CPT code (90673) and is fully reimbursed by most insurance companies.
Healthcare professionals seeking Flublok should contact one of the following distributors: FFF Enterprises at 800-843-7477 or online at www.myfluvaccine.com. FFF Enterprises will begin shipment immediately or delivery dates can be specified. Vaccine can also be obtained through ASD Healthcare at 800-746-6273 or online at www.asdhealthcare.com.
About Protein Sciences
Protein Sciences is a vaccine development and protein production company that is dedicated to saving lives and improving health through the creation of innovative vaccines and biopharmaceuticals.
Flublok, the world's first recombinant protein-based vaccine for the prevention of seasonal influenza disease, was approved by FDA in January 2013. Flublok is the only flu vaccine made in a 100% egg-free system using modern cell culture technology, making it unnecessary to use an infectious influenza virus or antibiotics in manufacturing. Flublok is highly purified and does not contain any preservatives (e.g., thimerosal, a mercury derivative), egg proteins, gelatin or latex. In addition, Flublok is triple the strength of conventional influenza vaccines. Flublok is a perfect copy of the virus coat and is not subject to the egg-adapted mutations associated with low vaccine effectiveness (see Skowronski et al. (2014) PLOS ONE 9(3), e92153). We have filed for FDA approval of Flublok for ages 50 and above and expect to receive approval in time for the 2014/15 influenza season.
Learn more at www.proteinsciences.com and www.Flublok.com.
Flublok Safety Information
Flublok is approved for people 18-49 years old to prevent influenza disease. The most common side effect from Flublok is pain at the site of injection. Other side effects may occur and include fatigue, headache and muscle aches.
Flublok should not be administered to anyone with a severe allergic reaction (e.g., anaphylaxis) to any vaccine component.
Tell the doctor if you have ever experienced Guillain-Barre syndrome (severe muscle weakness) within 6 weeks of receipt of a previous dose of influenza vaccine. If you notice any other problems or symptoms following vaccination, please contact your healthcare professional immediately. Vaccination with Flublok may not protect all individuals.
Please see the complete Package Insert available at www.Flublok.com or call 203-686-0800 for more information.
Logo - http://photos.prnewswire.com/prnh/20140617/118909
SOURCE Protein Sciences Corporation